This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Membership   Events   Resources   Accreditation Apr. 11, 2012

Cancer diagnosis linked to suicide, heart attack
WebMD    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Newly diagnosed cancer patients have an increased risk of suicide and death from heart attack and stroke, according to a new study. Research published in The New England Journal of Medicine finds that the risk is present even before treatment begins, and the risk was greatest among people with the most deadly cancers. The findings confirm that a cancer diagnosis may have an immediate affect on physical and emotional health that can lead to death, say researcher Unnur Valdimarsdottir, Ph.D., of the University of Iceland in Reykjavik. More

Fake cancer drug Avastin hits US market for the second time
CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Another batch of counterfeit cancer drugs have been discovered in the United States. A batch of 120 vials of fake Avastin, labeled under its Turkish name Alzutan, was shipped through the U.K. from Turkey. The pattern mimics the first time phony Avastin was found in the U.S. in February. "What we're seeing is a pattern of this risky practice of purchasing unapproved drugs from foreign suppliers," Connie Jung, a pharmacologist with the Food and Drug Administration's Office of Drug Security, Integrity and Recalls, told CBS News. More

Study: Injectable contraceptive doubles risk of breast cancer
CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An injectable form of birth control doubles breast cancer risk among young women, according to a new study. The study examined younger women, ages 20 to 44, and confirmed a link between depo-medroxyprogesterone acetate — the main ingredient in the contraceptive sold under the brand name Depo-Provera — and breast cancer risk. The contraceptive shot usually is injected into the buttocks or upper arm once every three months, or just under the skin once every 12 to 14 weeks. More

Peace of mind.

With an A (Excellent) rating by A.M. Best, we strongly protect and defend you. So you can relax and practice medicine.

Breast cancer: Women with false positive mammograms at higher risk
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study suggests "false alarms" in breast cancer screenings might not be so benign after all. A Danish study of more than 58,000 women found those who had false positive mammograms, meaning the results suggested breast cancer when there was none, had a 67 percent higher risk of developing breast cancer later in life compared with women who had negative mammograms. "The excess breast cancer risk in women with false-positive tests may be attributable to misclassification of malignancies already present at the baseline assessment ... or to a biological susceptibility for developing breast cancer in some women without malignancies at baseline," the study authors wrote, describing how dense, irregular breast tissue may disguise or develop into cancer. More

USDOJ: Georgia-based radiation oncology practice to pay $3.8 million to settle False Claims Act case
7thSpace Interactive    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Radiotherapy Clinics of Georgia LLC, a radiation oncology practice, and its affiliates RCOG Cancer Centers LLC, Physician Oncology Services Management Company LLC, Dr. Frank A. Critz and Physician Oncology Services L.P. (collectively, RCOG) agreed to pay $3.8 million to settle claims that they violated the False Claims Act, the Justice Department announced. RCOG, which is located in Decatur, Ga., allegedly billed Medicare for medical treatment that they provided to prostate cancer patients in excess of those permitted by Medicare rules and for services that were not medically necessary. More

Boston University takes on racial disparities in cancer
Boston University    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When epidemiologists Julie Palmer and Lynn Rosenberg launched the Black Women's Health Study in the early 1990s, they could state with confidence the number of long-term health studies of African-American women previously undertaken: zero. While it was clear that black women have higher rates of breast cancer at young ages, as well as a greater incidence of many illnesses such as hypertension, diabetes, stroke, and lupus, scientists could only guess at the reasons. More

Hospital to conduct clinical trials with DC therapy for cancer
The Times of India    Share    Share on FacebookTwitterShare on LinkedinE-mail article
There is a new ray of hope for cancer patients as a city hospital is in the process of conducting clinical trials with Dendritic Cell therapy, an FDA-approved mode of treatment for prostate cancer. Clinical trials will be conducted for use of this therapy for treatment of other cancers too as it relieves from the accepted modalities of cancer treatment including chemotherapy, radiation and surgery. More

ONCOCHART now in the cloud!

ONCOCHART, the 1st ARRA-certified RadOnc EMR, can be deployed either in a local environment or “cloud” environment. See us at ACRO Booth 21 for complete details.

Study: Low oxygen a predictor of prostate cancer recurrence
Toronto Star    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Men with low oxygen levels in their localized prostate tumors are more likely to have a recurrence of cancer after radiation treatment, a clinical research study led by radiation oncologists at the Princess Margaret Hospital Cancer Program in Toronto has found. Published online in Clinical Cancer Research, a journal of the American Association for Cancer Research, the study's findings came from following 247 men with localized prostate cancer prior to radiation therapy. All had the oxygen levels in their tumours measured and were monitored for a median of 6.6 years. More

Metal-on-metal hip implants not associated with early cancer
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients who have undergone metal-on-metal hip replacement have no increased risk for cancer for up to 7 years after their surgery, according to a study published online April 3 in the British Medical Journal. In the study, British researchers assessed cancer incidence in 40,576 patients who had undergone metal-on-metal hip replacement and 248,995 patients with alternative bearings. Results indicated that the rate of cancer 7 years after surgery was not significantly higher in those receiving metal-on-metal implants when compared with patients with alternative bearings or with age- and sex-matched men and women in the general population. More

Catalyst - Reinforcing the Treatment Chain
Improve patient throughput whilst ensuring patient safety. The Catalyst is an optical scanner which creates a 3D model of the patient surface and projects positional delta directly onto the patient providing continual feedback for the Therapist. Movement during the fraction is detected triggering a visual and audible alarm. more

When cancer 'boomerangs' the adult child
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Suleika Jaouad, 23, is chronicling her return to her parents' home, and to a life of being cared for, in a post on The New York Times's Well blog. Her "boomerang" back toward her childhood house came about as a result of her diagnosis of leukemia last year, and now, waiting for a bone marrow transplant, her life has become, she writes, a "slow emergency," her world "a waiting room." More

Colon screening more likely when patients pick test
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study finds that people are more likely to get screened for colorectal cancer when their doctors recommend they get a stool test instead of a colonoscopy, or when doctors leave it up to patients to choose which test to have. The results suggest doctors should take their patients' preferences into consideration before recommending one test or the other, according to the researchers. More

'Hot Dogs Cause Butt Cancer' billboard up by new Marlins stadium
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A health group wants Miami to know that hot dogs cause butt cancer. According to a new billboard just installed near Marlins Park, colorectal cancer risks are increased when eating processed meats, such as hot dogs. A public service ad by Physicians Committee for Responsible Medicine, the large billboard at 600 N.W. 57th Ave. features a man in a hospital gown, staring at his behind, with a hot dog in his hand. More
RadOnc Weekly
Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Patrick McCoy, Senior Content Editor, 469.420.2603   Contribute news
This edition of RadOnc Weekly was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
April 4, 2012
March 28, 2012
March 21, 2012
March 14, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063